Aspira Women’s Health (NASDAQ:AWH) Coverage Initiated at StockNews.com

StockNews.com initiated coverage on shares of Aspira Women’s Health (NASDAQ:AWHFree Report) in a research note published on Tuesday morning. The brokerage issued a hold rating on the stock.

Aspira Women’s Health Stock Performance

AWH stock opened at $0.72 on Tuesday. The stock’s 50 day moving average price is $0.79 and its 200 day moving average price is $1.00. The firm has a market cap of $11.96 million, a P/E ratio of -0.60 and a beta of 1.39. Aspira Women’s Health has a 1 year low of $0.67 and a 1 year high of $5.65.

Hedge Funds Weigh In On Aspira Women’s Health

An institutional investor recently raised its position in Aspira Women’s Health stock. B. Riley Wealth Advisors Inc. boosted its holdings in Aspira Women’s Health Inc. (NASDAQ:AWHFree Report) by 33.8% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 316,294 shares of the company’s stock after purchasing an additional 79,898 shares during the quarter. B. Riley Wealth Advisors Inc. owned approximately 1.90% of Aspira Women’s Health worth $256,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors own 12.19% of the company’s stock.

About Aspira Women’s Health

(Get Free Report)

Aspira Women's Health Inc, together with its subsidiaries, discovers, develops, and commercializes of noninvasive AI-powered diagnostic tests for gynecologic diseases in the United States. The company's products include Ova1Plus, a qualitative serum test to assess the likelihood of malignancy in women with an ovarian adnexal mass; Overa, a biomarker test intended to maintain Ova1's high sensitivity; and OvaWatch, a laboratory developed tests to assist in the initial clinical assessment of malignancy risk in all women thought to have an indeterminate or benign adnexal mass.

Read More

Receive News & Ratings for Aspira Women's Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspira Women's Health and related companies with MarketBeat.com's FREE daily email newsletter.